Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients (original) (raw)
Arpaci F, Yilmaz MI, Ozet A et al (2002) Low serum leptin level in colon cancer patients without significant weight loss. Tumori 88(2):147–149 PubMed Google Scholar
Baratta M (2002) Leptin—from a signal of adiposity to a hormone mediator in peripheral tissues. Med Sci Monit 8:RA282–RA292 PubMedCAS Google Scholar
Margetic S, Gazzola C, Pegg GG et al (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26:1407–1433 ArticlePubMedCAS Google Scholar
Mora S, Pessin JE (2002) An adipocentric view of signaling and intracellular trafficking. Diabetes Metab Res Rev 18:345–356 ArticlePubMedCAS Google Scholar
Beltowski J (2003) Adiponectin and resistin—new hormones of white adipose tissue. Med Sci Monit 9:RA55–RA61 PubMedCAS Google Scholar
Rohner-Jeanrenaud F, Jeanrenaud B (1996) The discovery of leptin and its impact in the understanding of obesity. Eur J Endocrinol 135:649–650 ArticlePubMedCAS Google Scholar
Friedman JM, Halaas J1 (1998) Leptin and the regulation of body weight in mammals. Nature 22:763–770 ArticleCAS Google Scholar
Faraj M, Havel PJ, Phelis S et al (2003) Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88:1594–1602 ArticlePubMedCAS Google Scholar
Ukkola O (2002) Resistin—a mediator of obesity associated insulin resistance or an innocent bystander? Eur J Endocrinol 147:571–574 ArticlePubMedCAS Google Scholar
Housa D, Housova J, Vernerova Z et al (2006) Adipocytokines and cancer. Physiol Res 55:233–244 PubMedCAS Google Scholar
Vendrell J, Broch M, Vilarrasa N et al (2004) Resistin, adiponectin, ghrelin, leptin and proinflammatory cytokines: relationships in obesity. Obes Res 12:962–971 ArticlePubMedCAS Google Scholar
Bray GA (2002) The underlying basis for obesity: relationship to cancer. J Nutr 132:3451S–3455S PubMedCAS Google Scholar
Jonsson F, Wolk A, Pedersen NL et al (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106:594–599 ArticlePubMedCAS Google Scholar
Rohrmann S, Platz EA, Smit E et al (2004) Body size and serum level of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 172:779 ArticlePubMed Google Scholar
Tamakoshi K, Toyoshima H, Wakai K et al (2005) Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncology 68(4–6):454–461 ArticlePubMedCAS Google Scholar
Frezza EE, Wachtel MS, Chiriva-Internati M (2006) Influence of obesity on the risk of developing colon cancer. Gut 55(2):285–291 ArticlePubMedCAS Google Scholar
Bolubkbas F, Kilic H, Bolukbas C et al (2004) Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 4:29 ArticleCAS Google Scholar
Tessitore L, Vizio B, Jenkins O et al (2000) Leptin expression in colorectal and breast cancer patients. Int J Mol Med 5(4):421–426 PubMedCAS Google Scholar
Arita Y, Kihara S, Ouchi M et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83 ArticlePubMedCAS Google Scholar
Hardwick JC, van Der Brink GR, Offerhause GJ (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121(1):79–90 ArticlePubMedCAS Google Scholar
Aparicio T, Kotelevets L, Tsocas A et al (2005) Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in APC(Min/+) mice. Gut 54(8):1136–1145 ArticlePubMedCAS Google Scholar
Hamilton SR, Aaltonen LA (2000) WHO classification of tumors pathology and genetics. Tumors of the digestive system. IARC, Lyon Google Scholar
Sobin LH, Wittekind C (2002) Classification of malignant tumors. Sixth edition
Simons JP, Schols AM, Campfirld LA et al (1997) Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond) 93:273–277 CAS Google Scholar
Wallace AM, Sattar N, McMillan DC (1998) Effect of weight loss and the inflammatory response on leptin concentration in gastrointestinal cancer patients. Clin Cancer Res 4:2977–2979 PubMedCAS Google Scholar
Frankenberry KA, Somasundar P, McFadden DW et al (2004) Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg 188:560–565 ArticlePubMedCAS Google Scholar
Hardwick JC, van Der Brink GR, Offerhause GJ (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121(1):79–90 ArticlePubMedCAS Google Scholar
Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14(2):189–206, Jun ArticlePubMedCAS Google Scholar
Mistry T, Digby JE, Desai KM et al (2007) Obesity and prostate cancer: a role for adipokines. Eur Urol 52(1):46–53, Jul ArticlePubMedCAS Google Scholar
Levy M, Visokai V, Lipska L et al (2008) Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma 55(2):138–142 PubMedCAS Google Scholar
Fukumoto J, Otake T, Tajima O et al (2008) Adiponectin and colorectal adenomas: self defense forces health study. Cancer Sci 99(4):781–786 ArticlePubMedCAS Google Scholar
Ishikawa M, Kitayama J, Kazama S et al (2005) Plasma adiponectin and gastric cancer. Clin Cancer Res 11:466–472 ArticlePubMedCAS Google Scholar
Wei E, Giovannucci E, Fuchs C et al (2005) Plasma adiponectin levels and risk of CC in men. JNCI 97(22):1688–1694 PubMedCAS Google Scholar
Wang B, Jenkins JR, Trayhurn P (2005) Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Integrated response to TNFα. Am J Physiol Endocrinol Metab 288:E731–E740 ArticlePubMedCAS Google Scholar
Williams CJ, Mitsiades N, Sozopulos E et al (2008) Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocrine-rel Cancer 15:289–299 ArticleCAS Google Scholar
Lehrke M, Reilly MP, Millington SC et al (2004) An inflammatory cascade leading to hyperresistinemia in human. PLoS Med 1:161–168 ArticleCAS Google Scholar
Silswal N, Singh AK, Aruna B et al (2005) Human resistin stimulates the pro-inflammatory cytokines TNF alpha and IL-12 in macrophages by NFkappaB dependent pathway. Biochem Biophys Res Commun 334:1092–1101 ArticlePubMedCAS Google Scholar
Kang JH, Yu BY, Youn DS (2007) Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 22(1):117–121, Feb PubMedCAS Google Scholar
Konrad A, Lehrke M, Schachinger V et al (2007) Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol 19(12):1070–1074, Dec ArticlePubMedCAS Google Scholar
Karmiris K, Koutroubakis IE, Xidakis C et al (2006) Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12(2):100–105, Feb ArticlePubMed Google Scholar
Mu H, Ohashi R, Yan S et al (2006) Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res 70(1):146–157, Apr 1 ArticlePubMedCAS Google Scholar
Calabro P, Samudio I, Willerson JT et al (2004) Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110(21):3335–3340, Nov 23 ArticlePubMedCAS Google Scholar